Prof. Keith Martin
Keith Martin is Managing Director of the Centre for Eye Research Australia and Ringland Anderson Professor and Head of Ophthalmology at the University of Melbourne. Martin is working to develop new treatments for eye disease using stem cells, gene therapy and other techniques.
About Prof. Keith Martin
Keith Martin is Managing Director of the Centre for Eye Research Australia and Ringland Anderson Professor and Head of Ophthalmology at the University of Melbourne. Before moving to Melbourne in January 2019, he was Head of Ophthalmology at the University of Cambridge, Deputy Director of the University’s John van Geest Centre for Brain Repair and an Affiliate Principal Investigator at the Wellcome Trust - MRC Cambridge Stem Cell Institute. He was also Academic Lead for Ophthalmology and Lead Clinician for Glaucoma at the Cambridge University Hospitals NHS Foundation Trust. He graduated from the University of Cambridge with First Class Honours in Medical Sciences and Neuroscience before completing clinical Training at Oxford University Clinical School, Ophthalmology Residency in Cambridge and Clinical and Research Fellowships in Glaucoma at Moorfields Eye Hospital in London and the Wilmer Eye Institute in Baltimore. He has been Chief Investigator for over 10 glaucoma clinical trials in the UK and co-founded the Cambridge Eye Research Centre as a Clinical Trials Unit in 2018.
Professor Martin is working to develop new treatments for eye disease using stem cells, gene therapy and other techniques. In 2010, Professor Martin won the ARVO Foundation for Eye Research Translational Research Award, an international prize to a researcher from any country under the age of 50 years whose research is judged to have the potential to lead to major breakthroughs in the treatment of eye disease. He was also a winner of the World Glaucoma Association Senior Clinician Scientist Award in 2011 and was awarded the Duke Elder Medal by the Royal College of Ophthalmologists in 2017.
He is co-founder of Quethera, a Cambridge-based gene therapy company which has developed a gene therapy for glaucoma that is currently progressing towards human clinical trials. His other current main research interest is in the potential for regeneration and repair of nerve damage in the eye and brain. Clinically, Professor Martin specialises in the medical and surgical management of glaucoma and he is also an expert in small incision cataract surgery. He is currently President of the World Glaucoma Association, the largest glaucoma organisation in the world.
Professor Martin is heavily involved in research and you can read more here.
MA BM BCh DM MRCP FRCOphth FRANZCO ALCM
Professor and Head of Ophthalmology – University of Melbourne
Managing Director – Centre for Eye Research Australia
Honorary Senior Research Fellow – University of Cambridge
Honorary Professor of Ophthalmology – University of Sydney
Senior Consultant Glaucoma Unit – Royal Victorian Eye and Ear Hospital
Fellow Royal Australian & New Zealand – College of Ophthalmologists
Fellow Royal College of Ophthalmologists (UK)
Fellow Association for Research in Vision and Ophthalmology
Member Royal College of Physicians (UK)